Literature DB >> 18973439

Proposal for Japanese encephalitis surveillance using captured invasive mongooses under an eradication project on Okinawa Island, Japan.

Mika Saito1, Katsushi Nakata, Taku Nishijima, Katsuhiro Yamashita, Anna Saito, Go Ogura.   

Abstract

A project to eradicate invasive small Asian mongooses (Herpestes javanicus) is underway to conserve the unique ecosystem of Okinawa Island, Japan. In the present study, we tried to elucidate whether the mongoose is a host of Japanese encephalitis virus (JEV) and to evaluate the reliability of surveillance of Japanese encephalitis (JE) using this species. Culex tritaeniorhynchus, the main vector mosquito of JEV, feeds on the mongoose. Eighty-five (35.4%) of 240 wild small Asian mongooses captured between 2001 and 2005 had neutralizing antibodies against more than one of four JEV strains. Prevalence rates of JEV antibodies tended to increase with body weight and length of the animals. One of three sentinel mongooses showed a temporal change in antibody titer. These results indicate that the small Asian mongooses on Okinawa Island are sensitive to JEV. From the antibody titers and the locations of capture, the JEV active area was clarified. We propose that surveillance of JE using mongooses captured under the eradication program is reliable.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18973439     DOI: 10.1089/vbz.2008.0099

Source DB:  PubMed          Journal:  Vector Borne Zoonotic Dis        ISSN: 1530-3667            Impact factor:   2.133


  2 in total

1.  Pathogenesis of Japanese encephalitis virus infection in a golden hamster model and evaluation of flavivirus cross-protective immunity.

Authors:  Angela Bosco-Lauth; Gary Mason; Richard Bowen
Journal:  Am J Trop Med Hyg       Date:  2011-05       Impact factor: 2.345

2.  North American birds as potential amplifying hosts of Japanese encephalitis virus.

Authors:  Nicole Nemeth; Angela Bosco-Lauth; Paul Oesterle; Dennis Kohler; Richard Bowen
Journal:  Am J Trop Med Hyg       Date:  2012-08-27       Impact factor: 2.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.